December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

12.50 +0.10 (+0.81%)
Streaming Delayed Price Updated: 10:35 AM EST, Dec 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million ↗
Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? ↗
Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? 
Via The Motley Fool
News headline image
AngioDynamics to Participate in the UBS Global Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List
From AngioDynamics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For October 2, 2025 ↗
 
Via Benzinga
News headline image
AngioDynamics Eyes Growth Despite Tariffs ↗
AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected. 
Via Benzinga
News headline image
Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Why Did AngioDynamics Stock Pop Today? ↗
Even 37 years after its founding, AngioDynamics still can't earn a profit. 
Via The Motley Fool
News headline image
What's Fueling The Momentum In AngioDynamics Stock? ↗
Shares of AngioDynamics, Inc. (NASDAQ: ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter. 
Via Benzinga
News headline image
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results ↗
 
Via Benzinga
News headline image
What's Next: AngioDynamics's Earnings Preview ↗
 
Via Benzinga
News headline image
AngioDynamics Inc (NASDAQ:ANGO) Surpasses Q1 Earnings Estimates and Raises Fiscal 2026 Outlook ↗
AngioDynamics (ANGO) beat Q1 FY2026 earnings and revenue estimates, driven by strong Med Tech growth. The company also raised its full-year financial outlook. 
Via Chartmill
News headline image
AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
From AngioDynamics, Inc.
Via Business Wire
News headline image
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
News headline image
S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗
CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level. 
Via Benzinga
Topics Stocks
News headline image
AngioDynamics, Globant And 3 Stocks To Watch Heading Into Thursday ↗
US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics. 
Via Benzinga
News headline image
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings ↗
 
Via Benzinga
News headline image
AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
From AngioDynamics, Inc.
Via Business Wire
News headline image
Recent Report Shows That Rep. Debbie Wasserman Schultz Bought Up to $15K Worth of Ichor Holdings Stock ↗
 
Via Benzinga
News headline image
AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
News headline image
A Congress Member Sold Up To $30K In AngioDynamics Stock: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology
From AngioDynamics, Inc.
Via Business Wire
News headline image
Why AngioDynamics Stock Popped, Then Dropped Today ↗
AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed. 
Via The Motley Fool
Topics Earnings
News headline image
AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting ↗
AngioDynamics expects a $4 million-$6 million impact from tariffs. Still, it's "profitable," CEO Jim Clemmer says. 
Via Benzinga
Topics World Trade
News headline image
AngioDynamics (ANGO) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth
From AngioDynamics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For July 15, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.